全文获取类型
收费全文 | 115篇 |
免费 | 14篇 |
专业分类
儿科学 | 1篇 |
妇产科学 | 2篇 |
基础医学 | 8篇 |
口腔科学 | 2篇 |
临床医学 | 7篇 |
内科学 | 62篇 |
神经病学 | 4篇 |
特种医学 | 6篇 |
外科学 | 12篇 |
预防医学 | 4篇 |
眼科学 | 15篇 |
药学 | 1篇 |
肿瘤学 | 5篇 |
出版年
2024年 | 1篇 |
2023年 | 1篇 |
2021年 | 1篇 |
2018年 | 2篇 |
2017年 | 4篇 |
2016年 | 3篇 |
2015年 | 1篇 |
2013年 | 3篇 |
2012年 | 2篇 |
2011年 | 3篇 |
2010年 | 10篇 |
2009年 | 4篇 |
2008年 | 12篇 |
2007年 | 12篇 |
2006年 | 4篇 |
2005年 | 8篇 |
2004年 | 6篇 |
2003年 | 7篇 |
2002年 | 5篇 |
2001年 | 3篇 |
1999年 | 3篇 |
1998年 | 5篇 |
1997年 | 1篇 |
1995年 | 1篇 |
1994年 | 1篇 |
1992年 | 2篇 |
1991年 | 2篇 |
1990年 | 1篇 |
1989年 | 2篇 |
1988年 | 2篇 |
1986年 | 1篇 |
1984年 | 1篇 |
1982年 | 3篇 |
1981年 | 1篇 |
1980年 | 1篇 |
1979年 | 2篇 |
1977年 | 1篇 |
1976年 | 1篇 |
1974年 | 1篇 |
1973年 | 2篇 |
1969年 | 1篇 |
1968年 | 1篇 |
1967年 | 1篇 |
排序方式: 共有129条查询结果,搜索用时 15 毫秒
1.
Determinants of liver damage associated with intravenous methylprednisolone pulse therapy in Graves' ophthalmopathy. 总被引:3,自引:0,他引:3
Rosario Le Moli Lelio Baldeschi Peerooz Saeed Noortje Regensburg Maarten P Mourits Wilmar M Wiersinga 《Thyroid》2007,17(4):357-362
BACKGROUND: Intravenous methylprednisolone pulses (IVMP) are more efficacious and better tolerated than oral prednisone in Graves' ophthalmopathy (GO) patients. However, acute and severe liver damage has been reported in sporadic cases during IVMP, resulting in fatal acute liver failure in four patients so far. The mechanism causing the liver damage is incompletely understood. DESIGN: We performed a prospective observational study in 13 patients with dysthyroid optic neuropathy (group A) and in 14 patients with moderately severe GO (group B) who were treated with high-dose (group A) or low-dose (group B) IVMP; cumulative steroid doses were 8.45 g in group A and 4.5 g in group B, and follow-up time was 24 weeks. MAIN OUTCOME: Slight increases in serum aminotransferases (in alanine aminotransferase [ALAT] more than in aspartate aminotransferase [ASAT]) were observed, in seven patients exceeding the upper normal limit of 40 U/L. These changes were more prominent in group A than in group B as was also evident from a decrease in ASAT/ALAT ratio in group A but not in group B. Changes in serum aminotransferases occurred especially in the first 6 weeks of IVMP, becoming smaller thereafter with the decrease in steroid dosage. Pretreatment liver steatosis or diabetes were not related to liver damage, but preexistent viral hepatitis was. CONCLUSION: IVMP in GO patients causes dose-dependent liver damage by a direct toxic effect of glucocorticoids on hepatocytes. Nevertheless, IVMP seems to be pretty safe if cumulative doses exceeding 8 g are avoided and liver function is checked before and at regular intervals during pulse therapy. 相似文献
2.
Mammalian Erv46 localizes to the endoplasmic reticulum-Golgi intermediate compartment and to cis-Golgi cisternae
下载免费PDF全文
![点击此处可从《Proceedings of the National Academy of Sciences of the United States of America》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Orci L Ravazzola M Mack GJ Barlowe C Otte S 《Proceedings of the National Academy of Sciences of the United States of America》2003,100(8):4586-4591
Yeast endoplasmic reticulum (ER) vesicle protein Erv46p is a novel membrane protein involved in transport through the early secretory pathway. Investigation of mammalian Erv46 (mErv46) reveals that it is broadly expressed in tissues and protein-secreting cells. By immunofluorescence microscopy, mErv46 displays a crescent-shaped perinuclear staining pattern that is characteristic of the Golgi complex. Quantitative immunoelectron microscopy indicates that mErv46 is restricted to the cis face of the Golgi apparatus and to vesicular tubular structures between the transitional ER and cis-Golgi. Minor amounts of mErv46 reside in ER membranes and later Golgi cisternae. On Brefeldin A treatment, mErv46 redistributes to punctate structures that costain for ERGIC53. Depletion of mErv46 protein by RNA interference caused no apparent structural changes in the intermediate compartment or Golgi complex. These findings place mErv46 in a group of itinerant proteins that cycle between the ER and Golgi compartments such as ERGIC53 and the p24 proteins. 相似文献
3.
4.
A resident Golgi protein is excluded from peri-Golgi vesicles in NRK cells 总被引:1,自引:0,他引:1
下载免费PDF全文
![点击此处可从《Proceedings of the National Academy of Sciences of the United States of America》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Cosson P Amherdt M Rothman JE Orci L 《Proceedings of the National Academy of Sciences of the United States of America》2002,99(20):12831-12834
To understand the structure and the function of the Golgi apparatus, it is essential to establish how resident Golgi enzymes are localized in only a few Golgi cisternae. In particular it is crucial to establish whether Golgi enzymes are retained specifically in cisternae, or if they are continuously transported from cisterna to cisterna. Here we report that a resident Golgi enzyme is largely excluded from peri-Golgi transport vesicles in normal rat kidney cells, a cell type in which conflicting results have been reported. Analysis of the lateral distribution of two markers within Golgi cisternae led to the same conclusion: a protein incorporated in vesicles (KDEL receptor) is concentrated at the rims of cisternae where vesicles form, while mannosidase II is not. These results suggest that localization of resident Golgi enzymes is achieved primarily by selective retention within cisternae and exclusion from transport vesicles. These observations cannot easily be reconciled with the vision of rapidly maturing Golgi cisternae as the principal means of intra-Golgi transport. 相似文献
5.
Jean-Louis Carpentier Max Fehlman Pierre Freychet Lelio Orci 《Molecular and cellular endocrinology》1982,28(3):543-550
Insulin binding and insulin internalization were studied in freshly isolated rat hepatocytes using a human insulin obtained by recombinant DNA technology. The results demonstrate that biosynthetic human insulin binds to rat liver receptors and is internalized by isolated rat hepatocytes at the same rate and magnitude as pork insulin. 相似文献
6.
Prummel MF Bakker A Wiersinga WM Baldeschi L Mourits MP Kendall-Taylor P Perros P Neoh C Dickinson AJ Lazarus JH Lane CM Heufelder AE Kahaly GJ Pitz S Orgiazzi J Hullo A Pinchera A Marcocci C Sartini MS Rocchi R Nardi M Krassas GE Halkias A 《European journal of endocrinology / European Federation of Endocrine Societies》2003,148(5):491-495
To improve management of patients with Graves' orbitopathy, a multi-center collaborative approach is necessary in order to have large enough sample sizes for meaningful randomized clinical trials. This is hampered by a lack of consensus on how to investigate the eye condition. The European Group on Graves' Orbitopathy aims to overcome this and has designed a preliminary case record form (CRF) to assess Graves' orbitopathy patients. This form was used in this first multi-center study. AIM: To investigate patient characteristics and treatment strategies in 152 new consecutively referred patients with thyroid eye disease seen in nine large European referral centers. METHODS: Newly referred patients with Graves' orbitopathy were included who were seen between September and December 2000. Demographic data and a complete ophthalmological assessment were recorded. RESULTS: One-hundred and fifty-two patients (77% females) were included. Diabetes was present in 9%, and glaucoma or cataract in 14% of patients. Forty percent were current smokers, 9% also had dermopathy, and only 33% reported a positive family history of thyroid disease. Mild eye disease was seen in 40%, moderately severe eye disease was seen in 33% and severe eye disease was seen in 28% of patients. Soft tissue involvement was the most frequent abnormality (seen in 75%), proptosis > or =21 mm was found in 63%, eye motility dysfunction in 49%, keratopathy in 16% and optic nerve involvement was found in 21% of patients. According to the clinical impression, 60% had active eye disease. Immunosuppressive treatment was planned more frequently in active patients (57/86; 66%) than in inactive patients (5/57, 9%; Chi-square 46.16; P<0.02). There were no important differences among the eight centers regarding the severity and the activity of their patients. CONCLUSIONS: In view of the large number of patients recruited in only 4 months, multi-center studies in the eight EUGOGO centers appear to be feasible. 相似文献
7.
Terwee CB Dekker FW Bonsel GJ Heisterkamp SH Prummel MF Baldeschi L Wiersinga WM 《Clinical endocrinology》2003,58(2):192-198
OBJECTIVES: The importance of facial disfigurement in many diseases necessitates a reliable and valid measure of disfigurement severity for clinical studies. The hypothesis is that a universal concept of disfigurement exists and can be measured in a reliable way. The objectives of this study were to investigate if persons, in particular patients and physicians, can agree on facial disfigurement severity; and to determine the relative contribution of predefined clinical characteristics of patients with Graves' ophthalmopathy (GO) to the overall rating of facial disfigurement severity. DESIGN: A panel study was carried out in four different panels, each consisting of four members. PATIENTS: We randomly selected 100 slide pairs of GO patients from four available study populations, involving mild, moderate and severe GO patients (mean age 49 years, 76% female) who were treated with either radiotherapy, sham-irradiation, prednisone or orbital decompression. MEASUREMENTS: All panel members individually scored the disfigurement severity of 100 GO patients shown on standardized slides on a Visual Analog Scale. In total, 1600 ratings were collected. We calculated within- and between-panel agreement of disfigurement severity and identified determinants of disfigurement. RESULTS: Agreement within a panel varied from 0.65 to 0.79 and was highest within the panel of ophthalmologists. Between-panel agreement was 0.67 and was highest between ophthalmologists and laypersons. Compared with the global average, patients overrated and endocrinologists underrated disfigurement severity. Female panellists rated the patients, on average, more disfigured than male panellists. Important determinants of disfigurement were eyelid retraction, severe eyelid swelling and proptosis. Their relative importance was consistent across panels and in contrast to current measures of GO severity. CONCLUSION: Facial disfigurement severity can be measured in a reliable way using panels of panellists. Except for some systematic differences between panellists, facial disfigurement does not seem to be in the eye of the beholder. 相似文献
8.
Sanguineti I. Tredici G. Beghi E. Aiello U. Boglium G. Lelio A. Di Tagliabue M. 《The Italian Journal of Neurological Sciences》1986,7(1):51-59
20 new cases of ataxic hemiparesis syndrome (AHS) are reported and the findings compared with those of published cases. AHS may be due to lesions either of the brainstem or of supratentorial structures, where motor fibers run together with the cerebro-cerebellar pathways. Specific syndromes related to the lesion site cannot be identified from the clinical signs. Ischemic infarct is the most frequent cause of the syndrome, but hemorrhagic, neoplastic and demyelinating lesions have also been reported.
Sommario Venti nuovi casi di emiparesi atassica sono stati osservati e confrontati con casi della letteratura. L'emiparesi atassica può conseguire a lesioni del tronco cerebrale o delle strutture sovratentoriali laddove le fibre motorie decorrono insieme alle vie cerebro-cerebellari. I quadri clinici osservati non consentono pertanto di identificare specifiche sindromi caratterizzate da danni anatomici comuni. Per quanto l'infarto ischemico ne sia di gran lunga la causa più frequente, l'emiparesi atassica è riportata anche in presenza di lesioni emorragiche, neoplastiche e demielinizzanti.相似文献
9.
10.
Grégory Lavieu Lelio Orci Lei Shi Michael Geiling Mariella Ravazzola Felix Wieland Pierre Cosson James E. Rothman 《Proceedings of the National Academy of Sciences of the United States of America》2010,107(15):6876-6881
Cortical endoplasmic reticulum (cER) is a permanent feature of yeast cells but occurs transiently in most animal cell types. Ist2p is a transmembrane protein that permanently localizes to the cER in yeast. When Ist2 is expressed in mammalian cells, it induces abundant cER containing Ist2. Ist2 cytoplasmic C-terminal peptide is necessary and sufficient to induce cER. This peptide sequence resembles classic coat protein complex I (COPI) coatomer protein-binding KKXX signals, and indeed the dimerized peptide binds COPI in vitro. Controlled dimerization of this peptide induces cER in cells. RNA interference experiments confirm that coatomer is required for cER induction in vivo, as are microtubules and the microtubule plus-end binding protein EB1. We suggest that Ist2 dimerization triggers coatomer binding and clustering of this protein into domains that traffic at the microtubule growing plus-end to generate the cER beneath the plasma membrane. Sequences similar to the Ist2 lysine-rich tail are found in mammalian STIM proteins that reversibly induce the formation of cER under calcium control.The current view of the yeast endoplasmic reticulum (ER) discriminates perinuclear ER from cortical ER (cER), which forms a circular structure apposed to the plasma membrane (PM) (1). Both structures are connected by tubulated membranes (2, 3), at least transiently, because ER membranes undergo continuous fission and fusion events (4, 5). cER is a much less prominent feature of most mammalian cells (6). The best-characterized function of cER is its role in the store-operated calcium entry, an ubiquitous Ca2+ influx pathway activated in response to depletion of intracellular calcium stores (7).Ist2 is a “yeast peripheral” protein involved in osmotic stress tolerance. It was initially believed to be located at the plasma membrane (8–11), and its cytosolic tail (Ist2ct) has been shown to carry the peripheral targeting signal (8). Ist2ct includes a dimerization domain (amino acids 878–928) and a lysine-rich carboxy terminal tail containing a KKXX-like motif that has been proposed to interact with the PM (11, 12). The nature of the peripheral Ist2 resident sites remains a matter of debate, however. It was once thought that Ist2 reached the PM in a new Golgi-independent manner (10), but more recently it has been concluded that the major residence site is in fact the cER (11).To gain insight into the biogenesis of cER in mammalian cells, we investigated whether Ist2, when expressed in a heterologous system, can serve as a useful marker for this compartment. Interestingly, enrichment of Ist2 chimeric protein at the cER appears to directly modulate the formation and/or maintenance of this ER subdomain. These dynamic changes in peripheral ER structure are absolutely dependent on both microtubules and coat protein complex I (COPI) and suggest a different role of COPI than its classical one. 相似文献